We are honored to be named by TIME Magazine as ‘Outstanding’ in the first ranking of World’s Top HealthTech Companies 2025 in the AI & Data Analytics category.
The new ranking showcases HealthTech companies that drive innovation, enhance accessibility, and contribute to a more effective and sustainable healthcare system. It is a world-class recognition of BC Platforms as a global technology leader pioneering innovation in Real-World Data (RWD) and predictive analytics for life sciences and healthcare.
Less than a fifth of all companies ranked merited the performance indicator ‘Outstanding,’ and we were the only European-based company to receive the highest recognition in the ‘AI & Data Analytics’ category.
I am immensely proud of our talented team for their pioneering work to accelerate innovation in life sciences and personalized medicine. Innovation is at the forefront of what we do – constantly striving to help transform drug development and precision medicine by enabling collaborative research and faster, more informed decisions. It’s an honor to have our efforts recognized by TIME magazine, one of the world’s most respected news publications.
Mukhtar Ahmed, Chief Executive Officer, BC Platforms
BC Platforms utilizes a unique AI-enabled federated architecture that spans the research continuum from drug discovery to commercialization and supports the delivery of precision medicine, providing deep and novel insights at a fraction of the cost and time most research using real-world data at this scale typically requires.
To determine the ranking, TIME partnered with global data and business intelligence platform Statista to identify 400 global companies delivering the most impactful technologies to improve health. The companies were ranked on three metrics—financial performance, reputation analysis, and online engagement, and classified into one of six HealthTech market segments. The companies with the highest scores have been recognized as the World’s Top HealthTech Companies.
Get in touch
For press and media inquiries, contact our communications team.
New commercial leaders join BC Platforms to drive further growth and global expansion
We welcome two senior leaders: Teresa Ley as SVP of Healthcare and Partnerships for North America and EMEA, and Andrew O’Brien as SVP of Life Sciences and Healthcare Sales for JAPAC.
BC Platforms appoints Mukhtar Ahmed as Chief Executive Officer to accelerate growth and Real-World Data innovation
BC Platforms names Mukhtar Ahmed as CEO, strengthening our leadership with his extensive global experience across life sciences, healthcare and data-driven innovation.